1-cyclohexyl-3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea
95%
- Product Code: 80004
CAS:
874297-81-1
Molecular Weight: | 344.25616 g./mol | Molecular Formula: | C₁₉H₂₉BN₂O₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD14585589 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in organic synthesis and medicinal chemistry as a key intermediate in the development of biologically active molecules. Its boronate ester functional group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct carbon-carbon bonds in the synthesis of pharmaceuticals, agrochemicals, and advanced materials. Additionally, the urea moiety in its structure can contribute to hydrogen bonding interactions, making it useful in the design of enzyme inhibitors or receptor ligands. Its application extends to the preparation of boron-containing compounds for potential use in cancer therapy, particularly in the development of proteasome inhibitors or other targeted therapies. The compound’s stability and reactivity also make it a candidate for use in chemical biology research, where it can serve as a probe or precursor for studying biological pathways.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.050 | 10-20 days | Ft87,076.34 |
+
-
|
0.250 | 10-20 days | Ft347,141.76 |
+
-
|
1-cyclohexyl-3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea
This compound is primarily utilized in organic synthesis and medicinal chemistry as a key intermediate in the development of biologically active molecules. Its boronate ester functional group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct carbon-carbon bonds in the synthesis of pharmaceuticals, agrochemicals, and advanced materials. Additionally, the urea moiety in its structure can contribute to hydrogen bonding interactions, making it useful in the design of enzyme inhibitors or receptor ligands. Its application extends to the preparation of boron-containing compounds for potential use in cancer therapy, particularly in the development of proteasome inhibitors or other targeted therapies. The compound’s stability and reactivity also make it a candidate for use in chemical biology research, where it can serve as a probe or precursor for studying biological pathways.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :